177 related articles for article (PubMed ID: 17476196)
1. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
Dehshal MH; Hooghooghi AH; Kebryaeezadeh A; Kheirabadi M; Kazemi S; Nasseh A; Shariftabrizi A; Pasalar P
Med Sci Monit; 2007 May; 13(5):CR235-9. PubMed ID: 17476196
[TBL] [Abstract][Full Text] [Related]
2. Zinc status in patients with major beta-thalassemia.
Mehdizadeh M; Zamani G; Tabatabaee S
Pediatr Hematol Oncol; 2008; 25(1):49-54. PubMed ID: 18231954
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
Suvarna J; Ingle H; Deshmukh CT
Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
[TBL] [Abstract][Full Text] [Related]
4. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine.
De Sanctis V; Borsari G; Brachi S; Govoni M; Carandina G
Georgian Med News; 2008 Mar; (156):74-7. PubMed ID: 18403814
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.
Hafez M; Youssry I; El-Hamed FA; Ibrahim A
Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and β cell function in patients with β-thalassemia major.
Ghergherehchi R; Habibzadeh A
Hemoglobin; 2015; 39(1):69-73. PubMed ID: 25572183
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
[TBL] [Abstract][Full Text] [Related]
9. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
Cario H; Stahnke K; Kohne E
Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
[TBL] [Abstract][Full Text] [Related]
10. Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism.
Mangiagli A; Campisi S; De Sanctis V; Nicoletti MC; Cardinale G; Galati MC; Raiola G; Rigano P; Saviano A;
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():272-5. PubMed ID: 16462710
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of impaired glucose metabolism in beta-thalassemic children receiving hypertransfusions with a suboptimal dosage of iron-chelating therapy.
Jaruratanasirikul S; Chareonmuang R; Wongcharnchailert M; Laosombat V; Sangsupavanich P; Leetanaporn K
Eur J Pediatr; 2008 Aug; 167(8):873-6. PubMed ID: 17899188
[TBL] [Abstract][Full Text] [Related]
12. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
Mangiagli A; Italia S; Campisi S
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():985-6. PubMed ID: 10091179
[No Abstract] [Full Text] [Related]
13. Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients.
Tsapas A; Vlachaki E; Christoforidis A; Sarigianni M; Bekiari E; Perifanis V; Tsapas V; Paletas K; Athanassiou-Metaxa M
Eur J Haematol; 2007 Dec; 79(6):526-30. PubMed ID: 17961176
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
Zuppinger K; Molinari B; Hirt A; Imbach P; Gugler E; Tönz O; Zurbrügg RP
Helv Paediatr Acta; 1979; 34(3):197-207. PubMed ID: 500381
[TBL] [Abstract][Full Text] [Related]
15. Intensification of chelating-therapy in patients with thalassemia major.
Laws HJ; Göbel U; Christaras A; Janssen G
Klin Padiatr; 2005; 217(3):120-5. PubMed ID: 15858702
[TBL] [Abstract][Full Text] [Related]
16. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
17. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the distribution of lymphocyte subsets and zinc levels in multitransfused beta-thalassemia major patients.
Al-Awadhi AM; Alfadhli SM; Al-Khaldi D; Borhama M; Borusly M
Int J Lab Hematol; 2010 Apr; 32(2):191-6. PubMed ID: 19453575
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.
Merkel PA; Simonson DC; Amiel SA; Plewe G; Sherwin RS; Pearson HA; Tamborlane WV
N Engl J Med; 1988 Mar; 318(13):809-14. PubMed ID: 3281000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
